Last-Chance cancer drug gets Real-World review
Disease control
Recruiting now
This study is looking back at medical records to see how well a drug called mosunetuzumab worked for adults with follicular lymphoma that came back or didn't respond to at least two other treatments. The drug was given through a special program for patients who had no other good …
Sponsor: Andrés José Maria Ferreri • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC